Mettler-Toledo International, Inc. $MTD Shares Purchased by Legal & General Group Plc

Legal & General Group Plc increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 3.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 175,410 shares of the medical instruments supplier’s stock after acquiring an additional 6,154 shares during the quarter. Legal & General Group Plc owned about 0.86% of Mettler-Toledo International worth $244,555,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MTD. Principal Financial Group Inc. raised its stake in Mettler-Toledo International by 2.9% during the third quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock worth $366,354,000 after purchasing an additional 8,360 shares during the period. Nordea Investment Management AB raised its stake in Mettler-Toledo International by 11.9% during the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after purchasing an additional 16,777 shares during the period. Machina Capital S.A.S. purchased a new position in Mettler-Toledo International during the third quarter worth about $1,186,000. Citigroup Inc. raised its stake in Mettler-Toledo International by 4.8% during the third quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock worth $79,835,000 after purchasing an additional 2,989 shares during the period. Finally, AustralianSuper Pty Ltd raised its stake in Mettler-Toledo International by 7.0% during the third quarter. AustralianSuper Pty Ltd now owns 126,734 shares of the medical instruments supplier’s stock worth $155,580,000 after purchasing an additional 8,333 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MTD shares. Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. JPMorgan Chase & Co. reduced their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Barclays reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Finally, Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Moderate Buy” and an average target price of $1,408.55.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,101.26 on Wednesday. Mettler-Toledo International, Inc. has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The company’s 50 day simple moving average is $1,224.79 and its 200-day simple moving average is $1,337.48. The company has a market capitalization of $22.26 billion, a price-to-earnings ratio of 25.83, a price-to-earnings-growth ratio of 2.30 and a beta of 1.31.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, topping the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same period in the prior year, the firm earned $8.19 EPS. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.